Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index |  Total Docs. (2011) |
Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 170 | 2009 IEEE 3rd International Conference on Nano/Molecular Medicine and Engineering, NANOMED 2009 | conference and proceedings | 0.114 | 6 | 0 | 70 | 0 | 11 | 69 | 0.16 | 0.00 |  |
| 169 | 2010 IEEE International Conference on Nano/Molecular Medicine and Engineering, IEEE NANOMED 2010 | conference and proceedings | 0.100 | 5 | 0 | 53 | 0 | 3 | 50 | 0.06 | 0.00 | |
| 168 | Advances in Pharmacological Sciences | journal | 0.270 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 167 | Cellular Oncology | journal | 1.405 Q2 | 44 | 0 | 106 | 0 | 280 | 83 | 2.99 | 0.00 |  |
| 166 | Current Opinion in Molecular Therapeutics | journal | 1.475 Q2 | 67 | 0 | 236 | 0 | 885 | 224 | 3.86 | 0.00 |  |
| 165 | Drugs in Context | journal | 0.101 Q4 | 36 | 0 | 20 | 0 | 0 | 18 | 0.00 | 0.00 | |
| 164 | Frontiers in Drug Design and Discovery | book series | 0.134 Q4 | 9 | 0 | 18 | 0 | 8 | 17 | 0.44 | 0.00 |  |
| 163 | Frontiers in Medicinal Chemistry | book series | 0.233 Q4 | 7 | 0 | 44 | 0 | 13 | 42 | 0.30 | 0.00 | |
| 162 | Gene Therapy and Molecular Biology | journal | 0.181 Q4 | 18 | 0 | 68 | 0 | 45 | 68 | 0.90 | 0.00 |  |
| 161 | Journal of Experimental Pharmacology | journal | 0.121 Q4 | 23 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 |  |
| 160 | MedChemComm | journal | 0.962 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 159 | Methods in molecular medicine | book series | 0.261 Q4 | 59 | 0 | 67 | 0 | 41 | 66 | 0.00 | 0.00 | |
| 158 | Methods in Pharmacology and Toxicology | book series | 0.112 Q4 | 14 | 0 | 22 | 0 | 4 | 21 | 0.00 | 0.00 | |
| 157 | Open Bioactive Compounds Journal | journal | 0.115 Q4 | 6 | 0 | 6 | 0 | 2 | 6 | 0.33 | 0.00 | |
| 156 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.103 Q4 | 40 | 0 | 6 | 0 | 0 | 6 | 0.00 | 0.00 | |
| 155 | Open Pharmacology Journal | journal | 0.384 Q3 | 6 | 1 | 9 | 28 | 6 | 9 | 0.67 | 28.00 | |
| 154 | BMC Chemical Biology | journal | 1.979 Q1 | 21 | 2 | 17 | 74 | 73 | 17 | 4.07 | 37.00 | |
| 153 | Nucleus (India) | journal | 17 | 4 | 0 | 84 | 0 | 0 | 0.00 | 21.00 |  | |
| 152 | Gene Therapy and Regulation | journal | 0.104 Q4 | 7 | 6 | 12 | 338 | 2 | 11 | 0.17 | 56.33 |  |
| 151 | Progress in Medicinal Chemistry | journal | 0.962 Q2 | 38 | 6 | 28 | 836 | 61 | 17 | 1.75 | 139.33 | |
| 150 | Topics in Medicinal Chemistry | book series | 0.108 Q4 | 15 | 8 | 25 | 1218 | 2 | 19 | 0.08 | 152.25 |  |
| 149 | Cellular Therapy and Transplantation | journal | 0.191 Q4 | 8 | 10 | 38 | 225 | 13 | 37 | 0.34 | 22.50 | |
| 148 | Pharmacogenomics and Personalized Medicine | journal | 0.147 Q4 | 37 | 11 | 20 | 1128 | 9 | 20 | 0.45 | 102.55 | |
| 147 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.118 Q4 | 29 | 11 | 18 | 591 | 7 | 0 | 0.40 | 53.73 | |
| 146 | Pteridines | journal | 0.113 Q4 | 19 | 12 | 35 | 444 | 9 | 34 | 0.23 | 37.00 | |
| 145 | Current Chemical Genomics | journal | 0.588 Q3 | 16 | 13 | 16 | 655 | 41 | 16 | 2.56 | 50.38 | |
| 144 | Open Medicinal Chemistry Journal | journal | 0.921 Q2 | 23 | 13 | 7 | 776 | 25 | 6 | 3.57 | 59.69 | |
| 143 | Molecular Aspects of Medicine | journal | 3.954 Q1 | 159 | 14 | 106 | 3394 | 1236 | 101 | 11.91 | 242.43 | |
| 142 | Drug Discovery Today: Disease Mechanisms | journal | 0.504 Q3 | 28 | 15 | 78 | 807 | 107 | 70 | 1.15 | 53.80 | |
| 141 | Genetic Vaccines and Therapy | journal | 0.758 Q3 | 30 | 15 | 36 | 621 | 93 | 36 | 1.85 | 41.40 | |
| 140 | Progress in Drug Research | book series | 0.760 Q3 | 46 | 15 | 20 | 1405 | 61 | 18 | 0.00 | 93.67 |  |
| 139 | Biomarker Insights | journal | 0.525 Q3 | 40 | 17 | 82 | 571 | 148 | 81 | 2.64 | 33.59 | |
| 138 | Clinical Proteomics | journal | 0.609 Q3 | 42 | 17 | 47 | 589 | 74 | 43 | 1.34 | 34.65 | |
| 137 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.497 Q3 | 45 | 18 | 97 | 1059 | 156 | 93 | 1.22 | 58.83 | |
| 136 | Current Molecular Pharmacology | journal | 1.689 Q1 | 49 | 18 | 64 | 2266 | 315 | 64 | 5.34 | 125.89 | |
| 135 | Drug Discovery Today: Technologies | journal | 0.414 Q3 | 62 | 18 | 64 | 601 | 89 | 56 | 1.15 | 33.39 | |
| 134 | MCB Molecular and Cellular Biomechanics | journal | 0.551 Q3 | 31 | 18 | 56 | 629 | 79 | 56 | 1.06 | 34.94 | |
| 133 | Molecular Interventions | journal | 1.295 Q2 | 78 | 20 | 114 | 839 | 345 | 106 | 2.29 | 41.95 | |
| 132 | Drug Discovery Today: Therapeutic Strategies | journal | 0.375 Q3 | 31 | 23 | 71 | 651 | 63 | 60 | 0.68 | 28.30 | |
| 131 | Drug Discovery Today: Disease Models | journal | 0.364 Q4 | 33 | 24 | 79 | 1114 | 74 | 68 | 0.63 | 46.42 | |
| 130 | Medicinal Research Reviews | journal | 3.242 Q1 | 150 | 24 | 83 | 4735 | 864 | 81 | 9.73 | 197.29 | |
| 129 | Current Enzyme Inhibition | journal | 0.183 Q4 | 19 | 25 | 63 | 2002 | 28 | 61 | 0.49 | 80.08 | |
| 128 | Probiotics and Antimicrobial Proteins | journal | 0.419 Q3 | 52 | 25 | 36 | 1178 | 50 | 35 | 1.39 | 47.12 | |
| 127 | Turkish Journal of Pharmaceutical Sciences | journal | 0.170 Q4 | 22 | 25 | 68 | 649 | 18 | 68 | 0.24 | 25.96 |  |
| 126 | Analytical Cellular Pathology | journal | 0.365 Q4 | 35 | 27 | 25 | 1153 | 27 | 24 | 1.08 | 42.70 |  |
| 125 | Molecular Cytogenetics | journal | 0.962 Q2 | 38 | 27 | 51 | 939 | 123 | 50 | 2.37 | 34.78 | |
| 124 | Current Cancer Therapy Reviews | journal | 0.143 Q4 | 17 | 28 | 104 | 3131 | 34 | 102 | 0.35 | 111.82 | |
| 123 | Advances in Biological Regulation | journal | 1.200 Q2 | 69 | 29 | 78 | 1641 | 171 | 75 | 2.30 | 56.59 | |
| 122 | Current Pharmacogenomics and Personalized Medicine | journal | 0.291 Q4 | 20 | 30 | 85 | 2789 | 112 | 75 | 1.61 | 92.97 | |
| 121 | European Pharmaceutical Review | trade journal | 0.104 Q4 | 9 | 30 | 72 | 542 | 5 | 64 | 0.07 | 18.07 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data